最近の臨床血液領域の話題と臨床検査(1)

司会のことば

上　平　　　憲*1　巽　　　典　之*2
　　　　　　　　　　　　　　　　　　　　　　
Recent Diagnostic and Therapeutic Progress in Hematology and its related Laboratory Tests
-Especially in Hematopoietic Neoplasms-
−Chairmen’s Introductory Remarks

Shimeru KAMIHIRA, MD*1 and Noriyuki TATSUMI, MD*2

In clinical hematology, especially in the field of hematopoietic neoplasms, molecular understanding has been providing new insight for not only classification of the diseases but also promising therapeutic strategies, such as the WHO classification and therapies using ATRA, STI571, and IDEC. On the other hand, the laboratory tests in hematology labs in Japan have not always been up to date with molecular diagnostic and therapeutic advances regarding hematopoietic neoplasms. Therefore, the present seminar was held to consider the near future advances in hematological laboratory testing.
[Rinsho Byori 51 : 818〜819, 2003]

*1Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501

【Key Words】WHO classification(WHO分類)，genetic diagnosis(遺伝子診断)，molecular target therapy(分子標的療法)，MRD(微量残存白血病)，BMT(骨髄移植)

*1長崎大学大学院医歯薬学総合研究科検査医学部門(〒852-8501 長崎市坂本1-7-1)
*2四天王寺国際仏教大学(〒583-8501 羽曳野市学園前3-2-1)

E-mail :kamihira@net.nagasaki-u.ac.jp